Literature DB >> 18835441

Solubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt.

Karine Andrieux1, Laura Forte, Sylviane Lesieur, Maité Paternostre, Michel Ollivon, Cécile Grabielle-Madelmont.   

Abstract

In order to better understand the mechanism of destabilization of liposomes used as drug carriers for oral administration by bile salts, the insertion and partition of sodium taurocholate (TC) into small unilamellar vesicles (SUV) and multilayers (ML) of dipalmitoylphosphatidylcholine (DPPC) were examined by continuous turbidity analysis and DSC. Optical density was recorded during the progressive solubilisation of DPPC SUV and ML into DPPC/TC mixed micelles by varying the rate of TC addition and the temperature. The results show that the insertion and diffusion of TC in the DPPC membrane is a slow process influenced by the polymorphism of the lipid, independently of its organisation. This dynamic study mimics physiological phenomena of the digestion of liposomes. In the gastrointestinal tract, DPPC SUV would be more resistant to TC than egg phosphatidylcholine (EPC) SUV [K. Andrieux, L. Forte, S. Lesieur, M. Paternostre, M. Ollivon, C. Grabielle-Madelmont, Insertion and partition of sodium taurocholate into egg phosphatidylcholine vesicles, Pharm. Res. 21 (2004) 1505-1516] because of the lower insertion of TC into DPPC bilayer at 37 degrees C at low TC concentration in the medium (fasted conditions). At high TC concentration (postprandially or after lipid absorption), the use of DPPC to prepare liposomes will delay or reduce the liberation of a drug encapsulated into liposomes in the gastrointestinal tract. As a conclusion, the addition of DPPC appears an attractive strategy to formulate orally administered liposomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835441     DOI: 10.1016/j.ejpb.2008.09.004

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  9 in total

1.  A novel compound inhibits reconstituted high-density lipoprotein assembly and blocks nascent high-density lipoprotein biogenesis downstream of apolipoprotein AI binding to ATP-binding cassette transporter A1-expressing cells.

Authors:  Nicholas N Lyssenko; Gregory Brubaker; Bradley D Smith; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

2.  Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin.

Authors:  Chong Li; Yan Zhang; Tingting Su; Lianlian Feng; Yingying Long; Zhangbao Chen
Journal:  Int J Nanomedicine       Date:  2012-12-05

3.  Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt.

Authors:  Peipei Guan; Yi Lu; Jianping Qi; Mengmeng Niu; Ruyue Lian; Fuqiang Hu; Wei Wu
Journal:  Int J Nanomedicine       Date:  2011-05-04

Review 4.  Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine.

Authors:  Yosra S R Elnaggar
Journal:  Int J Nanomedicine       Date:  2015-06-12

5.  Improvement of oral availability of ginseng fruit saponins by a proliposome delivery system containing sodium deoxycholate.

Authors:  Fei Hao; Yanxi He; Yating Sun; Bin Zheng; Yan Liu; Xinmei Wang; Yongkai Zhang; Robert J Lee; Lirong Teng; Jing Xie
Journal:  Saudi J Biol Sci       Date:  2015-10-09       Impact factor: 4.219

6.  An MRI-guided HIFU-triggered wax-coated capsule for supertargeted drug release: a proof-of-concept study.

Authors:  Simon Matoori; Maurizio Roveri; Peter Tiefenboeck; Annatina Romagna; Olha Wuerthinger; Orpheus Kolokythas; Johannes M Froehlich
Journal:  Eur Radiol Exp       Date:  2019-03-05

7.  Bolalipid-Doped Liposomes: Can Bolalipids Increase the Integrity of Liposomes Exposed to Gastrointestinal Fluids?

Authors:  Sindy Müller; Kai Gruhle; Annette Meister; Gerd Hause; Simon Drescher
Journal:  Pharmaceutics       Date:  2019-12-03       Impact factor: 6.321

8.  Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.

Authors:  Gelareh Arzani; Azadeh Haeri; Marjan Daeihamed; Hamid Bakhtiari-Kaboutaraki; Simin Dadashzadeh
Journal:  Int J Nanomedicine       Date:  2015-07-29

9.  Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.

Authors:  Gang Yang; Yaping Zhao; Yongtai Zhang; Beilei Dang; Ying Liu; Nianping Feng
Journal:  Int J Nanomedicine       Date:  2015-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.